Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...